See more : ExcelFin Acquisition Corp. (XFINW) Income Statement Analysis – Financial Results
Complete financial analysis of Tsubota Laboratory Incorporated (4890.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Tsubota Laboratory Incorporated, a leading company in the Healthcare industry within the Healthcare sector.
You may be interested
- Brother Industries, Ltd. (6448.T) Income Statement Analysis – Financial Results
- Elite Semiconductor Microelectronics Tech Inc (3006.TW) Income Statement Analysis – Financial Results
- Prodware (ALPRO.PA) Income Statement Analysis – Financial Results
- Total Brain Limited (TTBLF) Income Statement Analysis – Financial Results
- Newron Sport (NSPT) Income Statement Analysis – Financial Results
Tsubota Laboratory Incorporated (4890.T)
About Tsubota Laboratory Incorporated
Tsubota Laboratory Incorporated engages in the research and development of pharmaceuticals and medical devices for the treatment of myopia, dry eyes, and presbyopia. The company was incorporated in 2012 and is based in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 673.53M | 954.69M | 640.92M | 687.50M | 441.00M |
| Cost of Revenue | 653.00M | 235.56M | 83.90M | 80.74M | 164.00M |
| Gross Profit | 20.53M | 719.14M | 557.02M | 606.77M | 277.00M |
| Gross Profit Ratio | 3.05% | 75.33% | 86.91% | 88.26% | 62.81% |
| Research & Development | 205.00M | 126.00M | 116.00M | 108.22M | 81.92M |
| General & Administrative | 108.00M | 97.00M | 77.00M | 0.00 | 0.00 |
| Selling & Marketing | 327.00M | 297.00M | 199.00M | 0.00 | 0.00 |
| SG&A | 435.00M | 394.00M | 276.00M | 356.00M | 262.00M |
| Other Expenses | 29.00M | -8.98M | 67.19M | 4.82M | 0.00 |
| Operating Expenses | 670.93M | 552.11M | 420.85M | 356.52M | 274.00M |
| Cost & Expenses | 1.32B | 787.66M | 504.75M | 437.26M | 438.00M |
| Interest Income | 18.00K | 18.00K | 11.00K | 5.00K | 3.00K |
| Interest Expense | 1.01M | 778.00K | 1.03M | 1.30M | 697.00K |
| Depreciation & Amortization | 32.77M | 39.19M | 37.70M | 14.47M | -15.00M |
| EBITDA | -602.60M | 184.19M | 241.07M | 271.61M | 0.00 |
| EBITDA Ratio | -89.47% | 19.29% | 37.61% | 39.20% | -2.72% |
| Operating Income | -649.55M | 167.03M | 136.17M | 250.24M | 15.00M |
| Operating Income Ratio | -96.44% | 17.50% | 21.25% | 36.40% | 3.40% |
| Total Other Income/Expenses | 13.18M | -22.81M | 66.17M | 5.60M | -12.00M |
| Income Before Tax | -636.37M | 144.22M | 202.34M | 255.84M | 3.00M |
| Income Before Tax Ratio | -94.48% | 15.11% | 31.57% | 37.21% | 0.68% |
| Income Tax Expense | 4.95M | 54.04M | 49.02M | 54.23M | -12.00M |
| Net Income | -641.32M | 90.18M | 153.32M | 201.61M | 3.00M |
| Net Income Ratio | -95.22% | 9.45% | 23.92% | 29.32% | 0.68% |
| EPS | -25.15 | 3.66 | 6.77 | 8.97 | 0.12 |
| EPS Diluted | -25.15 | 3.52 | 6.77 | 8.97 | 0.12 |
| Weighted Avg Shares Out | 25.50M | 24.62M | 22.63M | 22.47M | 25.13M |
| Weighted Avg Shares Out (Dil) | 25.50M | 25.62M | 22.63M | 22.47M | 25.13M |
No news found for: 4890.T
Source: https://incomestatements.info
Category: Stock Reports